| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.
|
Proc Natl Acad Sci U S A
|
2002
|
1.92
|
|
2
|
Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing.
|
PLoS One
|
2010
|
1.63
|
|
3
|
Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.
|
Am J Hum Genet
|
2009
|
1.53
|
|
4
|
Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.
|
Mol Cell Proteomics
|
2010
|
1.52
|
|
5
|
DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination.
|
Biochem Biophys Res Commun
|
2010
|
1.52
|
|
6
|
Epstein-Barr virus latent membrane protein 1: structure and functions.
|
J Biomed Sci
|
2003
|
1.49
|
|
7
|
Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
|
Cancer Res
|
2006
|
1.38
|
|
8
|
Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
|
Proteomics
|
2005
|
1.32
|
|
9
|
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.
|
J Clin Invest
|
2013
|
1.19
|
|
10
|
Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
|
Int J Cancer
|
2011
|
1.19
|
|
11
|
Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins.
|
J Biol Chem
|
2002
|
1.18
|
|
12
|
Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells.
|
Cancer Res
|
2011
|
1.15
|
|
13
|
Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma.
|
EMBO Mol Med
|
2012
|
1.14
|
|
14
|
Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
|
J Proteome Res
|
2012
|
1.14
|
|
15
|
Adrenal cystic lesions: a clinicopathological analysis of 25 cases with proposed histogenesis and review of the literature.
|
Endocr Pathol
|
2008
|
1.14
|
|
16
|
Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
|
Mol Cell Proteomics
|
2012
|
1.14
|
|
17
|
Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology.
|
J Proteome Res
|
2010
|
1.10
|
|
18
|
Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
|
Proteomics
|
2008
|
1.09
|
|
19
|
Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology.
|
J Proteome Res
|
2011
|
1.06
|
|
20
|
Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma.
|
Head Neck
|
2011
|
1.04
|
|
21
|
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics.
|
J Proteomics
|
2013
|
1.02
|
|
22
|
A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma.
|
Mod Pathol
|
2010
|
1.01
|
|
23
|
Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
|
Clin Cancer Res
|
2008
|
1.01
|
|
24
|
Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry.
|
FEBS J
|
2010
|
1.00
|
|
25
|
Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.
|
J Proteomics
|
2012
|
0.99
|
|
26
|
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
|
Proteomics
|
2010
|
0.99
|
|
27
|
Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis.
|
J Proteome Res
|
2011
|
0.97
|
|
28
|
Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer.
|
Int J Cancer
|
2010
|
0.97
|
|
29
|
MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment.
|
Clin Cancer Res
|
2007
|
0.96
|
|
30
|
Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
|
Clin Cancer Res
|
2008
|
0.96
|
|
31
|
Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology.
|
J Proteome Res
|
2011
|
0.95
|
|
32
|
Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection.
|
PLoS One
|
2011
|
0.95
|
|
33
|
An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
|
Mol Cell Proteomics
|
2011
|
0.94
|
|
34
|
Targeted methylation of CMV and E1A viral promoters.
|
Biochem Biophys Res Commun
|
2010
|
0.94
|
|
35
|
Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival.
|
Head Neck
|
2010
|
0.94
|
|
36
|
Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome.
|
J Proteome Res
|
2009
|
0.94
|
|
37
|
Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.
|
Mol Cell Proteomics
|
2009
|
0.94
|
|
38
|
Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.
|
J Virol
|
2004
|
0.93
|
|
39
|
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
|
Biomaterials
|
2011
|
0.92
|
|
40
|
PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1.
|
EMBO J
|
2006
|
0.92
|
|
41
|
Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas.
|
Int J Clin Exp Pathol
|
2012
|
0.92
|
|
42
|
A gender-specific association of CNV at 6p21.3 with NPC susceptibility.
|
Hum Mol Genet
|
2011
|
0.92
|
|
43
|
Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer.
|
Genes Chromosomes Cancer
|
2010
|
0.91
|
|
44
|
Identification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancer.
|
Mol Med
|
2010
|
0.89
|
|
45
|
Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma.
|
Hum Pathol
|
2010
|
0.88
|
|
46
|
Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2013
|
0.88
|
|
47
|
Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas.
|
Biomaterials
|
2011
|
0.88
|
|
48
|
Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
|
PLoS Pathog
|
2012
|
0.87
|
|
49
|
High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.
|
Virchows Arch
|
2010
|
0.87
|
|
50
|
Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma.
|
Oncotarget
|
2013
|
0.87
|
|
51
|
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
|
Genes Chromosomes Cancer
|
2009
|
0.86
|
|
52
|
Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
|
Oral Oncol
|
2008
|
0.85
|
|
53
|
Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract.
|
Histol Histopathol
|
2013
|
0.85
|
|
54
|
Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways.
|
Cell Signal
|
2010
|
0.85
|
|
55
|
Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.
|
J Proteome Res
|
2014
|
0.85
|
|
56
|
High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
|
J Surg Oncol
|
2011
|
0.85
|
|
57
|
Functional characterization of Trip10 in cancer cell growth and survival.
|
J Biomed Sci
|
2011
|
0.84
|
|
58
|
Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
|
Cancer
|
2013
|
0.84
|
|
59
|
Construction and characterization of monoclonal antibodies specific to Epstein-Barr virus latent membrane protein 1.
|
J Immunol Methods
|
2004
|
0.84
|
|
60
|
Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes.
|
Mol Cell Proteomics
|
2012
|
0.83
|
|
61
|
The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
|
Anticancer Res
|
2012
|
0.83
|
|
62
|
Epstein-Barr virus latent membrane protein 2A upregulates UDP-glucose dehydrogenase gene expression via ERK and PI3K/Akt pathway.
|
Cell Microbiol
|
2008
|
0.83
|
|
63
|
Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer.
|
Clin Chem Lab Med
|
2010
|
0.82
|
|
64
|
Prognostic significance of Tiam1 expression in papillary thyroid carcinoma.
|
Virchows Arch
|
2011
|
0.82
|
|
65
|
Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma.
|
PLoS One
|
2012
|
0.82
|
|
66
|
Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.
|
BMC Cancer
|
2014
|
0.82
|
|
67
|
Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation.
|
Proteomics
|
2008
|
0.82
|
|
68
|
Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
|
Cancer Lett
|
2006
|
0.81
|
|
69
|
Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.
|
Clin Chim Acta
|
2011
|
0.81
|
|
70
|
A novel role of RASSF9 in maintaining epidermal homeostasis.
|
PLoS One
|
2011
|
0.80
|
|
71
|
Overexpression and elevated plasma level of tumor-associated antigen 90K/Mac-2 binding protein in colorectal carcinoma.
|
Proteomics Clin Appl
|
2008
|
0.80
|
|
72
|
Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration.
|
Mol Cell Proteomics
|
2010
|
0.80
|
|
73
|
Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression.
|
Biochem Pharmacol
|
2011
|
0.79
|
|
74
|
Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma.
|
Oral Oncol
|
2012
|
0.79
|
|
75
|
Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.
|
J Proteome Res
|
2014
|
0.79
|
|
76
|
Detection of annexin A autoantibodies in sera from colorectal cancer patients.
|
J Clin Gastroenterol
|
2011
|
0.78
|
|
77
|
Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein, BRAM1.
|
J Biol Chem
|
2002
|
0.78
|
|
78
|
The utility of a high-throughput scanning biosensor in the detection of the pancreatic cancer marker ULBP2.
|
Biosens Bioelectron
|
2012
|
0.78
|
|
79
|
Identification of a new in vivo phosphorylation site in the cytoplasmic carboxyl terminus of EBV-LMP1 by tandem mass spectrometry.
|
Biochem Biophys Res Commun
|
2006
|
0.78
|
|
80
|
Identification of SEC61β and its autoantibody as biomarkers for colorectal cancer.
|
Clin Chim Acta
|
2011
|
0.78
|
|
81
|
Analysis of BART7 microRNA from Epstein-Barr virus-infected nasopharyngeal carcinoma cells by capillary electrophoresis.
|
Anal Chem
|
2008
|
0.77
|
|
82
|
Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation.
|
Oncogene
|
2002
|
0.77
|
|
83
|
Lipid droplet pattern and nondroplet-like structure in two fat mutants of Caenorhabditis elegans revealed by coherent anti-Stokes Raman scattering microscopy.
|
J Biomed Opt
|
2014
|
0.77
|
|
84
|
Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma.
|
PLoS One
|
2013
|
0.76
|
|
85
|
Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma.
|
J Proteomics
|
2011
|
0.76
|
|
86
|
The MYND domain-containing protein BRAM1 inhibits lymphotoxin beta receptor-mediated signaling through affecting receptor oligomerization.
|
Cell Signal
|
2010
|
0.76
|
|
87
|
Multiplexed microRNA detection by capillary electrophoresis with laser-induced fluorescence.
|
J Chromatogr A
|
2011
|
0.76
|
|
88
|
Integrin-mediated membrane blebbing is dependent on sodium-proton exchanger 1 and sodium-calcium exchanger 1 activity.
|
J Biol Chem
|
2012
|
0.76
|
|
89
|
Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1.
|
Biochem Biophys Res Commun
|
2002
|
0.75
|
|
90
|
Rapid and highly sensitive method for influenza A (H1N1) virus detection.
|
Anal Chem
|
2012
|
0.75
|
|
91
|
Immobilization of enzyme and antibody on ALD-HfO2-EIS structure by NH3 plasma treatment.
|
Nanoscale Res Lett
|
2012
|
0.75
|
|
92
|
Sensitive detection of unlabeled oligonucleotides using a paired surface plasma waves biosensor.
|
Biosens Bioelectron
|
2012
|
0.75
|
|
93
|
Induction of chemosensitivity in nasopharyngeal carcinoma cells using a human papillomavirus regulatory sequence and the thymidine kinase gene.
|
J Biomed Sci
|
2002
|
0.75
|
|
94
|
Determination of the heterogeneity of DNA methylation by combined bisulfite restriction analysis and capillary electrophoresis with laser-induced fluorescence.
|
J Chromatogr A
|
2012
|
0.75
|
|
95
|
Mass accuracy improvement of reversed-phase liquid chromatography/electrospray ionization mass spectrometry based urinary metabolomic analysis by post-run calibration using sodium formate cluster ions.
|
Rapid Commun Mass Spectrom
|
2014
|
0.75
|